Aeterna Zentaris.

In humans, LHRH receptors are expressed in ovarian, endometrial, breasts, bladder, prostate and pancreatic tumors. AEZS-108 happens to be in Phase 2 trials for advanced LHRH receptor positive ovarian and endometrial tumor. Related StoriesNew findings reveal association between colorectal tumor and melanoma drug treatmentFDA grants accelerated authorization for Tagrisso to take care of individuals with advanced NSCLCNew RNA test of blood platelets may be used to detect location of cancerJuergen Engel, Ph.D., President and CEO of Aeterna Zentaris stated, ‘We are very happy with the collaboration with Almac who’ve proven knowledge in the development and validation of companion diagnostic equipment and potential biomarkers in tumor indications.‘An organization that underestimates the risk of having cancer is likely to underestimate the worthiness of early recognition and thus skip the whole procedure,’ said study author William Dale, MD, PhD, assistant professor of medication/geriatrics at the University of Chicago, ‘which might explain, in part, why African-American males are so often diagnosed later and thus have worse outcomes.’ Dale and colleagues collected data on what 243 individuals expected from their biopsies and their anxiousness levels while waiting around in a urology clinic. The average age of these patients was 63. Almost 40 % of the men had been African-American. Fifty-six % got at least a college education level. Despite being referred for biopsy because they were regarded as at elevated risk for prostate malignancy, usually due to a blood test, 55 % of the African-American men at the time of prostate biopsy said they had a zero % chance of having prostate malignancy .